PI
Pharmstandard International Portfolio holdings
AUM $29M
1-Year Return
2.12%
This Quarter Return
-8.14%
1 Year Return
+2.12%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$24.9M
AUM Growth
-$14.7M
(-37%)
Cap. Flow
-$4.52M
Cap. Flow
% of AUM
-18.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
4
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ALNA
Allena Pharmaceuticals, Inc. Common Stock
ALNA
|
+$2.07M |
| 2 |
Protagonist Therapeutics
PTGX
|
+$1.56M |
| 3 |
JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
|
+$743K |
| 4 |
Protara Therapeutics
TARA
|
+$147K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALNA
1
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $11.4M | 45.89% |
878,131
-159,136
| -15% | -$2.07M |
|
|
2
Protagonist Therapeutics
PTGX
$3.74B
| $5.04M | 20.23% |
750,632
-231,638
| -24% | -$1.56M |
|
|
JNCE
3
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $4.33M | 17.36% |
565,063
-97,000
| -15% | -$743K |
|
|
4
Protara Therapeutics
TARA
$119M
| $3.94M | 15.8% |
40,195
-1,503
| -4% | -$147K |
|
|
ARGS
5
DELISTED
Argos Therapeutics, Inc.
ARGS
| $136K | 0.55% |
826,153
| – | – |
|